|
⚲
|
| Direct Pointe Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001480104 |
| Sale | 2009-12-23 ($7.6 M Offered, $3.2 M Sold) |
| Fund | |
| Phone | 8018059700 |
| Address | 333 South 520 West Lindon, 84042 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Daniel Atkinson | |
| Ty Mattingly | |
| R Tidwell | |
| Alan Taylor | |
| Craig Wilcox | |
| Lawton Smith | |
| Jack Sunderlage | |
| Ronald Heinz Jr | |
| Michael Brown | |
| Jeff Morrin | |
| Alan Ayers | |
| Phillip Windley |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Next Frontier Ventures 18, a series of Assure Labs 2021, LLC
✚
|
0.0 | |
|
NextGen Abett LLC
✚
|
0.0 | |
|
NextGen Kasa LLC
✚
|
0.0 | |
|
NextGen Maven LLC
✚
|
0.0 | |
|
Next Level Marketing & Advertising Inc
✚
|
0.0 | |
|
Next Play Capital III, L.P.
✚
|
0.0 | |
|
Next Play Capital III Q, L.P.
✚
|
0.0 | |
|
Next Wave Residential Partners XI, LLC
✚
|
0.0 | |
|
Nexus Ventures VI, L.P.
✚
|
0.0 | |
|
Nextech V Oncology S.C.S., SICAV-SIF
✚
|
0.0 |